Solothurn, Switzerland (June 14, 2014)
Among more than 250 Swiss start-up companies, Swiss Medendi has won the prestigious W. A. de Vigier Award – endowed with CHF 100’000. The president of the W. A. de Vigier Foundation, Dr. Daniel Borer, highlighted Swiss Medendi as his personal favorite – not only because of his medical background but because of the simple and yet genius idea behind this innovative infusion device.
About W. A. de Vigier Foundation
Since its founding in 1987, the W.A. de Vigier Foundation has followed the goal to promote active economic development by directly financing entrepreneurs with innovative business ideas who want to start up performance- and growth- oriented businesses in Switzerland. Throughout its 25 years of existence, the Foundation has awarded over seven million Swiss francs of start-up capital. The results of this sponsorship are evident today in the more than 75 successful start-ups and the many new jobs they have created. For more information on the W. A. de Vigier Foundation, please visit www.devigier.ch.
About Swiss Medendi
Swiss Medendi SA is a Switzerland based start-up company offering a proprietary, cost-efficient and easy-to-use intravenous (IV) infusion device, the HC100, for safe administration of chemotherapeutics and other vesicant and irritant drugs – protecting patients’ veins and vessels from vesicant damages, and preventing patients from injuries and complications associated today with ports and catheters. Employing the HC100 will help hospitals to manage costs and enable doctors to focus more on their patients’ needs. For more information on Swiss Medendi, please visit www.swissmedendi.com.